CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Letters

• Publication date

  2009-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.canlet.2008.09.014PMID 18952369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peritumoral CpG oligodeoxynucleotide treatment inhibits tumor growth and metastasis of B16F10 melanoma cells.

  2004cited by this paper
• CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma.

  2003cited by this paper
• Peritumoral CpG DNA Elicits a Coordinated Response of CD8 T Cells and Innate Effectors to Cure Established Tumors in a Murine Colon Carcinoma Model1

  2002cited by this paper
• Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

  2001cited by this paper
• Antimetastatic effect of CpG DNA mediated by type I IFN.

  2001cited by this paper
• NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides1

  2001cited by this paper
• Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients.

  2001cited by this paper
• Novel Roles of CpG Oligodeoxynucleotides as a Leader for the Sampling and Presentation of CpG-Tagged Antigen by Dendritic Cells1

  2001cited by this paper
• Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs1

  2001cited by this paper
• CpG-DNA Activates In Vivo T Cell Epitope Presenting Dendritic Cells to Trigger Protective Antiviral Cytotoxic T Cell Responses1

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.

  2000cited by this paper
• Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.

  1998cited by this paper
• Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

  1998cited by this paper
• CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

  1997cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Growth Hormone Inhibits Tumor Metastasis

  1991cited by this paper
• The biology of cancer metastasis and implications for therapy.

  1987cited by this paper
• Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

  1984cited by this paper
• Biological diversity in metastatic neoplasms: origins and implications.

  1982cited by this paper
• The pathogenesis of cancer metastasis

  1980cited by this paper
• Cancer metastasis: a product of tumor-host interactions.

  1979cited by this paper
• Surgical treatment of parotid tumors

  1966cited by this paper

• Emerging nanoparticle platforms for CpG oligonucleotide delivery.

  2024cites this paper
• Nifuroxazide in combination with CpG ODN exerts greater efficacy against hepatocellular carcinoma.

  2022cites this paper
• Immune Modulator and Low-Temperature PTT-Induced Synergistic Immunotherapy for Cancer Treatment.

  2021cites this paper
• Uniform small graphene oxide as an efficient cellular nanocarrier for immunostimulatory CpG oligonucleotides.

  2014cites this paper
• Die Interaktion der plasmazytoiden dendritischen Zelle mit dem CD8+ T-Lymphozyten

  2014cites this paper
• Toll-like receptor signalling and their therapeutic targeting in colorectal cancer.

  2013cites this paper
• Thymosin Apha 1–A Peptide Immune Modulator with a Broad Range of Clinical Applications

  2013cites this paper
• Anti‐tumor activity of CpG‐ODN aerosol in mouse lung metastases

  2013cites this paper
• Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines

  2011cites this paper
• CpG Oligodeoxynucleotide Stimulates Protective Innate Immunity Against Human Renal Cell Carcinoma Xenografted in Nude Mice

  2011cites this paper
• Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice.

  2010cites this paper
• A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine.

  2010cites this paper
• Toll-like receptors as therapeutic targets in gastrointestinal diseases

  2010cites this paper
• UNIVERSITÁ DEGLI STUDI DI MILANO FACOLTÁ DI MEDICINA E CHIRURGIA

  2010cites this paper
• Role of TLRs in the pathophysiology and therapy of GI diseases

  2010cites this paper
• TLR3 activation inhibits nasopharyngeal carcinoma metastasis via down-regulation of chemokine receptor CXCR4

  2009cites this paper
• Improvement of Rituximab Efficiency in Chronic Lymphocytic Leukemia by CpG‐Mediated Upregulation of CD20 Expression Independently of PU.1

  2009cites this paper
• Immunoregulation of GVHD by triggering the innate immune system with CpG

  2009cites this paper
• Bibliography. Current world literature.

  2009cites this paper
• Antibody Carriers of CpG Oligodeoxynucleotides for Solid Tumor Immunotherapy

  2009cites this paper
• Immunoregulatory activities of nanoparticle-forming oligodeoxynucleotides

  2009cites this paper
• Self-nanoparticle forming immunostimulatory DNA : structure-function relationship studies

  2009cites this paper